Tuesday, October 25, 2016

Bamipine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D04AA15,R06AX01

CAS registry number (Chemical Abstracts Service)

0004945-47-5

Chemical Formula

C19-H24-N2

Molecular Weight

280

Therapeutic Categories

Antiallergic agent

Histamine, H₁-receptor antagonist

Chemical Name

4-Piperidinamine, 1-methyl-N-phenyl-N-(phenylmethyl)-

Foreign Names

  • Bamipinum (Latin)
  • Bamipin (German)
  • Bamipine (French)
  • Bamipina (Spanish)

Generic Names

  • Bamipine (OS: DCF, BAN)
  • Piperamine (IS)

Brand Names

  • Soventol Gel
    Medice, Austria


  • Soventol
    Medice, Germany; Medice, Poland; Nicholas, India; Oramon, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Kaolin Mixture for Children





1. Name Of The Medicinal Product



Kaolin Mixture for Children or Children's Diarrhoea Mixture


2. Qualitative And Quantitative Composition



Kaolin light (grade A1) BP 1.0g per 5ml.



3. Pharmaceutical Form



Solution/mixture



4. Clinical Particulars



4.1 Therapeutic Indications



For relief of the symptoms of diarrhoea and upset stomachs in children.



4.2 Posology And Method Of Administration



Oral.



Recommended doses



Children up to 1 year of age: one 5ml spoonful.



Children 1 – 5 years of age: two 5ml spoonfuls.



Directions for use: shake the bottle.



To be repeated every four hours as required.



4.3 Contraindications



Contraindicated in intestinal obstruction; and in patients with known hypersensitivity to kaolin or any of the other constituents.



4.4 Special Warnings And Precautions For Use



Rehydration therapy may be necessary because of fluid and electrolyte depletion.



Keep all medicines out of the reach and sight of children.



If symptoms persist for more than 3 days consult your doctor.



Use with medical advice for infants under 1 year.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



As kaolin is an adsorbent, the absorption of other drugs from the gastrointestinal tract administered concomitantly may be reduced.



4.6 Pregnancy And Lactation



Although not relevant in childrens use, as with all medicines the use of this product should be avoided in pregnancy and lactation unless advised by a doctor.



4.7 Effects On Ability To Drive And Use Machines



None, although not relevant in children.



4.8 Undesirable Effects



None known.



4.9 Overdose



In the unlikely event of overdose, treatment should be symptomatic.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Kaolin is an adsorbent, it adsorbs toxic and other substances from the alimentary tract and increases the bulk of the faeces.



5.2 Pharmacokinetic Properties



Kaolin is not absorbed following oral administration. It remains unchanged throughout transit of the gastrointestinal tract.



5.3 Preclinical Safety Data



None.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Raspberry juice concentrated BP, syrup BP, benzoic acid BP, propylene glycol BP, chloroform BP and purified water BP.



6.2 Incompatibilities



None



6.3 Shelf Life



100ml: 36 months unopened, discard 8 weeks after first opening.



500ml: 36 months unopened, discard 8 weeks after first opening.



6.4 Special Precautions For Storage



Store below 25°C.



6.5 Nature And Contents Of Container



100ml: Amber glass bottle with plastic lined cap or polypropylene child-resistant cap with saranex faced EPE liner or white 28mm Child-resistant cap with Tamper Evident band and EPE/Saranex Liner.



500ml: Amber glass bottle with plastic lined cap or polypropylene child-resistant cap with saranex faced EPE liner or white 28mm Child-resistant cap with Tamper Evident band and EPE/Saranex Liner.



6.6 Special Precautions For Disposal And Other Handling



None.



7. Marketing Authorisation Holder



L.C.M Ltd



Linthwaite Laboratories



Huddersfield



HD7 5QH



8. Marketing Authorisation Number(S)



PL 12965/0020



9. Date Of First Authorisation/Renewal Of The Authorisation



07 January 1994



10. Date Of Revision Of The Text



10/11/2008




Zirtek Allergy Relief for Children






Zirtek



ALLERGY RELIEF for children



cetirizine hydrochloride



What You Should Know About Your Medicine


Please read this leaflet carefully before you start taking this medicine.


It provides a summary of the information currently available on Zirtek Allergy Relief For Children.


For further information or advice ask your doctor or pharmacist.






What Is In Zirtek Allergy Relief For Children


Each pack contains 70 ml of a banana flavoured, sugar free oral solution; each ml containing 1 mg of cetirizine hydrochloride as the active ingredient. This medicine also contains sorbitol (E420), glycerol (E422), propylene glycol, saccharin sodium, methyl hydroxybenzoate (E218), propyl hydroxybenzoate (E216), banana flavouring, sodium acetate (E262), acetic acid (E260) and purified water.



Product licence number: PL 00039/0541



This medicine is manufactured and licenced by:




UCB Pharma Ltd


208 Bath Road


Slough


Berkshire

SL1 3WE





When Is Zirtek Allergy Relief For Children Used


Your medicine belongs to the antihistamine group of drugs.



This medicine treats adults & children aged 6 years and over: suffering from hay fever (seasonal allergic rhinitis), year round allergies such as dust or pet allergies (perennial allergic rhinitis) and urticaria (swelling, redness and itchiness of the skin).


Antihistamines like ZIRTEK Allergy Relief For Children relieve the unpleasant symptoms and discomfort associated with the above conditions, such as sneezing, irritated, runny and blocked up nose, itchy, red and watering eyes and skin rashes.





Before Taking Zirtek Allergy Relief For Children


If you are pregnant or if your doctor has told you that you have kidney problems, you should consult your doctor before taking this medicine. You should not take this medicine if you are breastfeeding or if you have ever had an allergic reaction to any of its constituents (see ‘What is in ZIRTEK Allergy Relief For Children’).


Your medicine contains methylhydroxybenzoate (E218) and propylhydroxybenzoate (E216) which may cause allergic reactions (possibly delayed) and glycerol (E422) which may cause headache, stomach upset and diarrhoea. If you have been told by
your doctor that you have an intolerance to some sugars, contact your doctor before taking ZIRTEK Allergy Relief For Children.


As with all antihistamines, you should avoid excessive alcohol consumption when taking this medicine.


If you have ever had a reaction to an antihistamine in the past consult your doctor or pharmacist before taking this solution.





How To Take Your Medicine



Adults, and children aged 6 years and over: Two 5 ml spoonfuls once a day or one 5 ml spoonful in the morning and another 5 ml spoonful in the evening.


You may feel drowsy or dizzy, taking half your dose twice a day may reduce this. If you accidentally take more than the recommended dose consult your doctor immediately.


This solution should not be given to children under 6 years of age.



REMEMBER... If you forget to take a dose, you should take one as soon as you remember, but wait at least 24 hours before taking the next dose.



DO NOT EXCEED THE STATED DOSE


If symptoms persist consult your doctor or pharmacist.





After Taking Zirtek Allergy Relief For Children


This medicine does not cause side-effects in most people. However, as with all medicines, some people can react differently. If you:


  • have frequent headaches

  • have an upset stomach

  • become agitated

  • have diarrhoea

  • get a dry mouth

  • feel weak and/or unwell

  • experience unusual touch sensation

  • experience fatigue, dizziness or drowsiness

  • experience itchiness and skin rash


Stop taking the solution and tell your doctor.


Other rare side effects have been reported such as bleeding and bruising easily, rapid heart beat, difficulty focussing, blurred vision, swelling, allergic reaction/shock, changes in liver function, fits, confusion, depression, aggression,
weight increase, unusual limb movements, experience a bad taste in the mouth, fainting, hallucination, insomnia, bed wetting, pain and/or difficulty passing water, red and/or blotchy skin rash.


If you notice anything unusual or have these or any other unexpected effects stop taking the solution and tell your doctor.


This solution does not normally cause drowsiness. However, individuals can react differently to treatment. If you are affected you should not drive or operate machinery, but should persist with the solution as any drowsiness doesn’t usually
last very long.






Storing Your Medicine.


Keep this medicine out of reach and sight of children.


Store the solution below 30°C


Do not use after the expiry date shown under Exp on the end panel of the carton.




LEGAL STATUS: GSL.


Date of preparation of this leaflet: October 2005


© UCB 2004 Cod. I 31661/3






Zometa 4mg / 5ml Concentrate for Solution for Infusion






Zometa 4 mg/5 ml concentrate for solution for infusion


Zoledronic acid



Read all of this leaflet carefully before you are given Zometa.


  • Keep this leaflet. You may need to read it again.

  • If you have any further questions, ask your doctor, nurse or pharmacist.

  • If any of the side effects gets serious, or if you notice side effects not listed in this leaflet, please
    tell your doctor, nurse or pharmacist.




In this leaflet


  • 1. What Zometa is and what it is used for

  • 2. Before you are given Zometa

  • 3. How Zometa is used

  • 4. Possible side effects

  • 5. How to store Zometa

  • 6. Further information




What Zometa Is And What It Is Used For


The active substance in Zometa is zoledronic acid, which belongs to a group of substances called bisphosphonates. Zoledronic acid works by attaching itself to the bone and slowing down the rate of bone change. It is used:



  • To treat bone metastases (spread of cancer from the primary cancer site to the bone) and to prevent associated/related bone complications, e.g. fractures.


  • To reduce the amount of calcium in the blood in cases where it is too high due to the presence of a tumour. Tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumour-induced hypercalcaemia (TIH).



Before You Are Given Zometa


Follow carefully all instructions given to you by your doctor.


Your doctor will carry out blood tests before you start treatment with Zometa and will check your response to treatment at regular intervals.



You should not be given Zometa:


  • if you are breast-feeding.

  • if you are allergic (hypersensitive) to zoledronic acid, another bisphosphonate (the group of substances to which Zometa belongs), or any of the other ingredients of Zometa.



Before you are given Zometa, tell your doctor:


  • if you have or have had a liver problem.

  • if you have or have had a kidney problem.

  • if you have or have had a heart problem.

  • if you have or have had pain, swelling or numbness of the jaw, a feeling of heaviness in the jaw or loosening of a tooth.

  • if you are having dental treatment or are due to undergo dental surgery, tell your dentist that you are being treated with Zometa.



Using other medicines


Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. It is especially important that you tell your doctor if you are also taking:


  • Aminoglycosides (medicines used to treat severe infections), since the combination of these with bisphosphonates may cause the calcium level in the blood to become too low.

  • Thalidomide or any other medicines which may harm your kidneys.



Patients aged 65 years and over


Zometa can be given to people aged 65 years and over. There is no evidence to suggest that any extra precautions are needed.




Use in children


There have been 2 studies on the use of Zometa in children with severe osteogenesis imperfecta (a genetic disorder, also called “brittle bone disease”). However, it has not been established whether these children will benefit from Zometa treatment.




Pregnancy and breast-feeding


You should not be given Zometa if you are pregnant. Tell your doctor if you are or think that you may be pregnant.


You must not be given Zometa if you are breast-feeding.


Ask your doctor for advice before taking any medicine while you are pregnant or breast-feeding.




Driving and using machines


The effects of Zometa on driving, using machines and performing other tasks that need your full attention have not been studied. However, there have been very rare cases of drowsiness with the use of Zometa. You should therefore be careful when driving, using machinery or performing other tasks that need full attention.





How Zometa Is Used


  • Your doctor will recommend that you drink enough water before each treatment to help prevent dehydration.

  • Carefully follow all the other instructions given to you by your doctor, nurse or pharmacist.


How much Zometa is given


  • The usual single dose given is 4 mg.

  • If you have a kidney problem, your doctor will give you a lower dose depending on the severity of your kidney problem.



How Zometa is given


  • Zometa is given as a drip (infusion) into a vein which should take at least 15 minutes and should be administered as a single intravenous solution in a separate infusion line.

Patients whose blood calcium levels are not too high will also be prescribed calcium and vitamin D supplements to be taken each day.




How often you will be given Zometa


  • If you are being treated for bone metastases, you will be given one infusion of Zometa every three to four weeks.

  • If you are being treated to reduce the amount of calcium in your blood, you will normally only be given one infusion of Zometa.



If you are given more Zometa than you should be


If you have received doses higher than those recommended, you must be carefully monitored by your doctor. This is because you may develop serum electrolyte abnormalities (e.g. abnormal levels of calcium, phosphorus and magnesium) and/or changes in kidney function, including severe kidney impairment. If your level of calcium falls too low, you may have to be given supplemental calcium by infusion.





Possible Side Effects


Like all medicines, Zometa can cause side effects, although not everybody gets them. The most common ones are usually mild and will probably disappear after a short time.


The frequency of possible side effects listed below is defined using the following convention:


  • very common: affects more than 1 user in 10

  • common: affects 1 to 10 users in 100

  • uncommon: affects 1 to 10 users in 1,000

  • rare: affects 1 to 10 users in 10,000

  • very rare: affects less than 1 user in 10,000

  • not known: frequency cannot be estimated from the available data.


Tell your doctor about any of the following side effects as soon as possible:



Very common:


  • Low level of phosphate in the blood.


Common:


  • Headache and a flu-like syndrome consisting of fever, fatigue, weakness, drowsiness, chills and bone, joint and/or muscle ache. In most cases no specific treatment is required and the symptoms disappear after a short time (couple of hours or days).

  • Gastrointestinal reactions such as nausea and vomiting as well as loss of appetite.

  • Conjunctivitis, as reported with other bisphosphonates (the group of substances to which Zometa belongs).

  • Blood tests indicating changes in kidney function (higher levels of creatinine), including severe kidney impairment. Such changes are also known to occur with other medicinal products of this kind. In addition, some cases of kidney disease have been reported.

  • Low level of red blood cells (anaemia).

  • Low level of calcium in the blood.


Uncommon:


  • Pain in the mouth, teeth and/or jaw, swelling or sores inside the mouth, numbness or a feeling of heaviness in the jaw, or loosening of a tooth. These could be signs of bone damage in the jaw (osteonecrosis). Tell your doctor and dentist immediately if you experience such symptoms.

  • Hypersensitivity reactions.

  • Low blood pressure.

  • Chest pain.

  • Skin reactions (redness and swelling) at the infusion site, rash, itching.

  • High blood pressure, shortness of breath, dizziness, sleep disturbances, tingling or numbness of the hands or feet, diarrhoea.

  • Low counts of white blood cells and blood platelets.

  • Low level of magnesium and potassium in the blood. Your doctor will monitor this and take any necessary measures.


Rare:


  • Slow heart beat.

  • Confusion.


Very rare:


  • Fainting due to low blood pressure.

  • Severe bone, joint and/or muscle pain, occasionally incapacitating.

  • Painful redness and/or swelling of the eye.

Irregular heart rhythm (atrial fibrillation) has been seen in patients receiving zoledronic acid for postmenopausal osteoporosis. It is currently unclear whether zoledronic acid causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received zoledronic acid.




If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please
tell your doctor, nurse or pharmacist.




How To Store Zometa


Your doctor, nurse or pharmacist knows how to store Zometa properly (see section 6).




Further Information



What Zometa contains


  • The active substance of Zometa is zoledronic acid.

  • The other ingredients are: mannitol, sodium citrate, water for injections.



What Zometa looks like and contents of the pack


Zometa is supplied as a liquid concentrate in a vial. One vial contains 4 mg of zoledronic acid.


Each pack contains the vial with concentrate. Zometa is supplied as packs containing 1, 4 or 10 vials.


Not all pack sizes may be marketed.




Marketing Authorisation Holder



Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

United Kingdom




Manufacturer



Novartis Pharma GmbH

Roonstrasse 25

D-90429 Nuremberg

Germany



For any further information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

































United Kingdom

Novartis Pharmaceuticals UK Ltd.

Tel: +44 1276 698370



This leaflet was last approved in January 2010





Monday, October 24, 2016

Dicobalt Edetate Injection 300mg (Cambridge Laboratories)






What you should know about Dicobalt Edetate Injection


This leaflet contains information about Dicobalt Edetate Injection, which will have already been given to you by injection into one of your veins. Although you will not be taking this medicine yourself, this leaflet contains important information to help you understand how Dicobalt Edetate Injection is used.


Always follow your doctor`s advice, and if there is anything you do not understand, please ask your doctor or nurse to explain it.





What does Dicobalt Edetate Injection contain


Dicobalt Edetate Injection is a sterile for injection. Each ampoule contains 300mg of dicobalt edetate, which is the active ingredient, 4 g of dextrose (glucose) monohydrate and water. Six ampoules are supplied in each pack.


Dicobalt Edetate Injection reacts with cyanide in the blood and stops the cyanide from causing death.


The holder of the product licence for this medicine is



Medicis Limited

Cricketers

Turgis Green

Hook

Nr Basingstoke

RG27 0AH


The ampoules are made by



Delpharm Tours

Rue Paul Langevin - BP 90241

37172 Chambray-les-Tours Cedex

France




What is Dicobalt Edetate Injection used for?


Dicobalt Edetate Injection is used only as a cure for cyanide poisoning.




When should Dicobalt Edetate Injection not be used?


Dicobalt Edetate Injection should not be used when the poisoning is so mild that the patient is fully awake, or for any condition other than cyanide poisoning.




How Dicobalt Edetate Injection is used


Dicobalt Edetate Injection is always given slowly into the blood stream. The usual dose is one ampoule over 1 to 5 minutes. This can be repeated if the patient does not recover. Other emergency treatment is usually given at the same time.




Side-effects


Dicobalt Edetate Injection may make you sick. It may also cause your blood pressure to fall, making you feel faint, and increase the rate at which your heart is beating. After this you will recover. If you have swelling of the face and neck, chest pain, sweating, an irregular heartbeat or a rash this may mean that too much Dicobalt Edetate has been given. In this case it is very important that the doctor treating you knows about these side-effects straight away.


If you think that Dicobalt Edetate Injection has caused any other side-effects, please tell your doctor or pharmacist (chemist) about it.




Storing Dicobalt Edetate Injection


Dicobalt Edetate Injection should be stored at room temperature (below 25°C) away from light. It should be used before the expiry date printed on the ampoule and carton. All medicines should be kept out of the reach of children.



Date of preparation of this leaflet: July 2005





Candiplas




Candiplas may be available in the countries listed below.


Ingredient matches for Candiplas



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Candiplas in the following countries:


  • Bahrain

  • Oman

  • Sri Lanka

  • Taiwan

International Drug Name Search

Emselex 15mg prolonged release tablets






Emselex 15 mg prolonged-release tablets


Darifenacin



Read all of this leaflet carefully before you start taking this medicine.


  • Keep this leaflet. You may need to read it again.

  • If you have any further questions, ask your doctor or pharmacist.

  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.




In this leaflet:


  • 1. What Emselex is and what it is used for

  • 2. Before you take Emselex

  • 3. How to take Emselex

  • 4. Possible side effects

  • 5. How to store Emselex

  • 6. Further information




What Emselex Is And What It Is Used For



How Emselex works


Emselex reduces the activity of an overactive bladder. This enables you to wait longer before you go to the toilet and it increases the amount of urine that your bladder can hold.




What Emselex can be used for


Emselex belongs to a class of medicines which relax the muscles of the bladder. It is used in adults for the treatment of the symptoms of overactive bladder conditions - such as a sudden urge to rush to the toilet, needing to go to the toilet frequently and/or not getting to the toilet in time and wetting yourself (urge incontinence).





Before You Take Emselex



Do not take Emselex:


  • if you are allergic (hypersensitive) to darifenacin or any of the other ingredients of Emselex.

  • if you suffer from urinary retention (inability to empty your bladder).

  • if you have gastric retention (problems emptying the contents of the stomach).

  • if you suffer from uncontrolled narrow-angle glaucoma (high pressure in the eyes with loss of eyesight that is not being adequately treated).

  • if you have myasthenia gravis (a disease marked by abnormal tiredness and weakness of selected muscles).

  • if you have severe ulcerative colitis or toxic megacolon (acute dilation of the colon due to complication of infection or inflammation).

  • if you have severe liver problems.

  • There are some medicines such as ciclosporin (a medicine used in transplantation to prevent organ rejection or for other conditions, e.g. rheumathoid arthritis or atopic dermatitis), verapamil (a medicine used to lower blood pressure, to correct heart rhythm or to treat angina pectoris), antifungal medicines (e.g. ketoconazole and itraconazole) and some antiviral medicines (e.g. ritonavir) that must not be taken with Emselex.



Take special care with Emselex:


  • if you have autonomic neuropathy (damage to the nerves that communicate between the brain and internal organs, muscles, skin, and blood vessels to regulate vital functions, including the heart rate, blood pressure and bowel function) - your doctor will have told you if you have this.

  • if you have heartburn and belching.

  • if you have difficulties in passing urine and a weak stream of urine.

  • if you have severe constipation (less than or equal to 2 bowel movements per week).

  • if you have a digestive motility disorder.

  • if you have an obstructive gastrointestinal disorder (any obstruction of the passage of intestinal or gastric contents, such as narrowing of the pylorus, the lower part of the stomach) - your doctor will have told you if you have this.

  • if you are taking medicinal products that can cause or worsen inflammation of the oesophagus such as oral bisphosphonates (a class of medicinal products that prevent the loss of bone mass and are used to treat osteoporosis).

  • if you are receiving treatment for narrow-angle glaucoma.

  • if you have liver problems.

  • if you have kidney problems.

If any of these apply to you, tell your doctor before you take Emselex.



Use in children (age below 18 years)


Emselex is not recommended for use in children.




Taking other medicines with Emselex


Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is particularly important if you are taking any of the following as your doctor may need to adjust your dose of Emselex and/or the other product: certain antibiotics (e.g. erythromycin, clarithromycin and rifampicin), antifungal medicines (e.g. ketoconazole and itraconazole), antipsychotic medicines (e.g. thioridazine), certain antidepressants (e.g. imipramine), antiviral medicines (e.g. nelfinavir and ritonavir), certain anticonvulsants (carbamazepine, barbiturates), certain medicines used to treat heart problems (e.g. flecainide, verapamil and digoxin) and other antimuscarinic medicines (e.g. tolterodine, oxybutynin and flavoxate). Please also inform your doctor if you are taking products containing St John’s wort.




Taking Emselex with food and drink


Eating food has no effect on Emselex. Grapefruit juice may interact with Emselex. However, the adjustment of Emselex doses is not necessary.




Pregnancy and breast-feeding


If you are pregnant or think you may be pregnant, tell your doctor. Emselex is not recommended during pregnancy.


If you are breast-feeding, ask your doctor for advice. Emselex should be taken with caution while breastfeeding.




Driving and using machines


Emselex may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. If you have any of these symptoms whilst taking Emselex, consult your doctor for advice on changing the dose or considering an alternative treatment. You should not drive or use machines if you are affected by these symptoms. For Emselex, these side effects have been reported to be uncommon (see section 4).





How To Take Emselex


Always take Emselex exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. If you have the impression that the effect of Emselex is too strong or too weak, talk to your doctor or pharmacist.



How much Emselex to take


The recommended starting dose, including for patients aged over 65 years, is 7.5 mg daily. Depending on your response to Emselex, your doctor may increase your dose to 15 mg daily, two weeks after starting therapy.


These doses are suitable for people with mild liver problems or people with kidney problems.


Take Emselex tablets once a day with water, at about the same time each day.


The tablet may be taken with or without food. Swallow the tablet whole. Do not chew, split or crush it.




How long to take Emselex


Your doctor will tell you how long your treatment with Emselex will last. Do not stop treatment early because you do not see an immediate effect. Your bladder will need some time to adapt. Finish the course of treatment prescribed by your doctor. If you have not noticed any effect by then, discuss it with your doctor.




If you take more Emselex than you should


If you have taken more tablets than you have been told to take, or if someone else accidentally takes your tablets, go to your doctor or hospital for advice immediately. When seeking medical advice, make sure that you take this leaflet and your remaining tablets with you to show them to the doctor. People who have taken an overdose may have dry mouth, constipation, headache, indigestion and nasal dryness. Overdose with Emselex may lead to severe symptoms requiring emergency treatment in hospital.




If you forget to take Emselex


If you forget to take Emselex at the usual time, take it as soon as you remember, unless it is the time for your next dose. Do not take a double dose to make up for a forgotten dose.




If you stop taking Emselex


It has been shown that taking all doses at the appropriate times can greatly increase the effectiveness of your medicine. Therefore, it is important to keep taking Emselex correctly, as described above. Do not stop taking Emselex until your doctor tells you to. You should not experience any effects when you stop treatment.



If you have any further questions on the use of this product, ask your doctor or pharmacist.




Possible Side Effects


Like all medicines, Emselex can cause side effects, although not everybody gets them. The side effects caused by Emselex are usually mild and temporary.


These side effects may occur with certain frequencies, which are defined as follows:


  • very common: affects more than 1 patient in 10

  • common: affects 1 to 10 patients in 100

  • uncommon: affects 1 to 10 patients in 1,000

  • rare: affects 1 to 10 patients in 10,000

  • very rare: affects less than 1 patient in 10,000

  • not known: frequency cannot be estimated from the available data.


Some side effects could be serious


Serious allergic reactions including swelling, mainly of the face and throat.




Other side effects



Very common side effects


Dry mouth, constipation.



Common side effects


Headache, abdominal pain, indigestion, feeling sick, dry eyes.



Uncommon side effects


Fatigue, accidental injury, facial swelling, high blood pressure, diarrhoea, flatulence, inflammation of the mucous membrane of the mouth, increased liver enzymes, swelling, dizziness, sleeplessness, drowsiness, abnormal thinking, runny nose (rhinitis), cough, shortness of breath, dry skin, itching, rash, sweating, visual disturbance including blurred vision, taste disturbance, urinary tract disorder or infection, impotence, discharge and itching in the vagina, bladder pain, inability to empty your bladder.



If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.




How To Store Emselex


  • Keep out of the reach and sight of children.

  • Do not use after the expiry date which is stated on the carton.

  • Keep the blister packs in the outer carton in order to protect from light.

  • Do not use if the pack is damaged or shows signs of tampering.



Further Information



What Emselex contains


  • The active substance is darifenacin (as hydrobromide). Each tablet contains 15 mg darifenacin.

  • The other ingredients are calcium hydrogen phosphate (anhydrous), hypromellose, magnesium stearate, polyethylene glycol, talc, titanium dioxide (E171), red iron oxide (E172) and yellow iron oxide (E172).



What Emselex looks like and contents of the pack


Emselex 15 mg prolonged-release tablets are round, convex light peach tablets and are debossed with “DF” on one side and “15” on the other.


The tablets are available in blister packs containing 7, 14, 28, 49, 56 or 98 tablets or in multipacks containing 140 (10x14) tablets. Not all pack sizes may be available in your country.




Marketing Authorisation Holder



Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex

RH12 5AB

United Kingdom




Manufacturer



Novartis Pharma GmbH

Roonstraße 25

D-90429 Nuremberg

Germany



If you have any questions about this medicine, please contact the local representative of the Marketing Authorisation Holder.
































United Kingdom

Novartis Pharmaceuticals UK Ltd.

Tel:+44 1276 698370




This leaflet was last approved in September 2009.